Meg is the Group Editorial Director for Cannabis Patient Care and Cannabis Science and Technology magazines at MJH Life Sciences.

Megan L'Heureux

Articles

Let’s meet Cannabis Science Conference Fall speaker Dr. Travis Poonai, a pharmacist with a specialty in medical cannabis. 

Meet the Cannabis Science Conference Fall Speakers: Dr. Travis Poonai on His Pharmacist Journey, Patient Trends, and Practitioner Experiences

Let’s meet Cannabis Science Conference Fall speaker Dawn-Marie Steenstra, a Clinical Director of Dispensaries in Maryland, and a founder for the National Clinical Director Consortium. 

Meet the Cannabis Science Conference Fall Speakers: Dawn-Marie Steenstra on Medical Cannabis Patient Advocacy

Madeline Colli is the Associate Editor for Cannabis Patient Care and Cannabis Science and Technology magazines at MJH Life Sciences.

Dr. Peter Grinspoon, a primary care doctor at Massachusetts General Hospital, an Instructor in Medicine at Harvard Medical School, and a 25-year cannabis specialist, will be a keynote speaker at the upcoming Cannabis Science Conference Fall taking place September 21-22, 2023 in Providence, Rhode Island. Here, Dr. Grinspoon shares his background and interest in medical cannabis as well some policies he’d like to see changed in the future. 

Meet the Cannabis Science Conference Fall Keynote: Dr. Peter Grinspoon

Hear what the business director of a cannabis testing facility has to say about the future of the cannabis industry!

Insights from a Cannabis Laboratory Business Director: Navigating Opportunities in the Evolving Industry


In this recent interview, Bruce Kendall  and Dr. Hinanit Koltai of the Volcani Institute share the inspiring story of the late Michelle Kendall and how her passion for science and research brought them all together to study medical cannabis as a potential treatment for ovarian cancer.

Ovarian Cancer and Medical Cannabis Research: Michelle Kendall’s Legacy of Research, Advocacy, and Change

In a statement released from the White House on October 6, 2022, President Joe Biden announced plans to pardon Federal convictions for simple possession of marijuana and issued a call to review the scheduling of cannabis (1).

US President Joe Biden Announces Cannabis Possession Pardons at the Federal Level and Calls for a Schedule Review

One of the recurring challenges in the medical cannabis space is the difficulty in conducting research because of the plant’s Schedule I status. Although there are some researchers diving in with special licenses to conduct clinical studies, there are others that are looking at real-world users to supply data. For instance, Dr. Daniel J. Kruger is a Research Investigator with the Population Study Center at the University of Michigan and Principal Investigator on a study being conducted with the Releaf app. Here, Dr. Kruger shares his interest and background in these types of surveys and his plans for the current study with Releaf on chronic pain.

Chronic Pain Research Endeavors: How an App and University Are Presenting Real-World Patient Data

Americans for Safe Access (ASA) is a non-profit dedicated to ensuring safe and legal access to cannabis for therapeutic use and research. ASA was founded in 2002 by medical cannabis patient, Steph Sherer, as a vehicle for patients to advocate for the acceptance of cannabis as medicine. ASA has local chapters throughout the United States, and in this series of interviews, we introduce you to those chapters and highlight some of the state-level work being done to advocate for patients’ access and rights. In this installment, Nico Murillo, the chair of the Dallas, Texas chapter, shares some advocacy highlights from the lone star state.  

Americans for Safe Access Local Chapters: Meet the Dallas, Texas ASA Chapter

Here, Tetragram shares an overview of some of the top four areas users reported on related to pain to see what type of products they are finding useful, how they are consuming it, and more.

Chronic Pain: Data Snapshot

In this interview series, we speak to each of the organizers to learn more about them and what attends can expect from the practicum. Here in Part III, Dr. Dustin Sulak shares his insights.